Nonsteroidal Antiinflammatory Drugs: A New Generation of Cyclooxygenase Inhibitors

The multitalented therapeutic agent that is used to relieve a variety of ailments, acetylsalicylic acid (Aspirin®) is facing new competition. The goal is to use tailor‐made inhibitors of cyclooxygenase‐2 to selectively reduce pain while minimizing side effects. Do these new drugs represent a new gen...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie (International ed.) Vol. 38; no. 5; pp. 631 - 633
Main Author Beuck, Martin
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag GmbH 01.03.1999
WILEY‐VCH Verlag GmbH
Subjects
Acetylsalicylic acid
Arthritis
Cyclooxygenases
Rheuma
Cyclooxygenases
Arthritis
Acetylsalicylic acid
Rheuma
Online AccessGet full text

Cover

More Information
Summary:The multitalented therapeutic agent that is used to relieve a variety of ailments, acetylsalicylic acid (Aspirin®) is facing new competition. The goal is to use tailor‐made inhibitors of cyclooxygenase‐2 to selectively reduce pain while minimizing side effects. Do these new drugs represent a new generation of nonsteroidal pain relievers?
Bibliography:ark:/67375/WNG-CXB9KK0F-N
istex:6563EB010B2B059485617186F0DC129B2A9A49BF
ArticleID:ANIE631
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
DOI:10.1002/(SICI)1521-3773(19990301)38:5<631::AID-ANIE631>3.0.CO;2-S